PL370829A1 - Leczenie glejaka tymozyną-alfa1 - Google Patents

Leczenie glejaka tymozyną-alfa1

Info

Publication number: PL370829A1
Authority: PL; Poland
Prior art keywords: thymosin; glioblastoma; treatment; alpha; alpha1
Prior art date: 2001-12-10

Application number

PL02370829A

Other languages

English (en)

Inventor

Jack R. Wands

La Monte Suzanne De

Original Assignee

Rhode Island Hospital

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-10

Filing date

2002-12-10

Publication date

2005-05-30

2002-12-10 Application filed by Rhode Island Hospital filed Critical Rhode Island Hospital

2005-05-30 Publication of PL370829A1 publication Critical patent/PL370829A1/pl

Links

108010078233 Thymalfasin Proteins 0.000 title abstract 2
102400000800 Thymosin alpha-1 Human genes 0.000 title abstract 2
208000005017 glioblastoma Diseases 0.000 title abstract 2
NZVYCXVTEHPMHE-ZSUJOUNUSA-N thymalfasin Chemical compound CC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O NZVYCXVTEHPMHE-ZSUJOUNUSA-N 0.000 title abstract 2
229960004231 thymalfasin Drugs 0.000 title abstract 2
DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 abstract 2
239000002671 adjuvant Substances 0.000 abstract 1
229960005243 carmustine Drugs 0.000 abstract 1
230000003211 malignant effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Prostheses (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL02370829A 2001-12-10 2002-12-10 Leczenie glejaka tymozyną-alfa1 PL370829A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33714901P	2001-12-10	2001-12-10

Publications (1)

Publication Number	Publication Date
PL370829A1 true PL370829A1 (pl)	2005-05-30

Family

ID=23319320

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02370829A PL370829A1 (pl)	2001-12-10	2002-12-10	Leczenie glejaka tymozyną-alfa1

Country Status (22)

Country	Link
US (1)	US20060166870A1 (pl)
EP (1)	EP1461063B1 (pl)
JP (1)	JP2005516910A (pl)
KR (2)	KR20100029844A (pl)
CN (1)	CN1615147A (pl)
AT (1)	ATE356628T1 (pl)
AU (1)	AU2002357115B2 (pl)
BR (1)	BR0214848A (pl)
CA (1)	CA2469595A1 (pl)
DE (1)	DE60218896T2 (pl)
DK (1)	DK1461063T3 (pl)
EA (1)	EA005822B1 (pl)
ES (1)	ES2283653T3 (pl)
IL (1)	IL162434A0 (pl)
MX (1)	MXPA04005585A (pl)
NO (1)	NO20042927L (pl)
NZ (1)	NZ533942A (pl)
PL (1)	PL370829A1 (pl)
PT (1)	PT1461063E (pl)
SI (1)	SI1461063T1 (pl)
UA (1)	UA77999C2 (pl)
WO (1)	WO2003049697A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2288118B1 (es)	2006-05-10	2008-11-01	Bcn Peptides, S.A.	Procedimiento para sintetizar timosinas.
CN108226016A (zh) *	2018-01-12	2018-06-29	浙江普罗亭健康科技有限公司	肿瘤免疫细胞亚群精准分型的质谱流式检测试剂盒
CN112147326B (zh) *	2020-09-04	2022-04-08	北京大学	一种肿瘤免疫细胞亚群分型精准检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4079127A (en) *	1976-10-28	1978-03-14	Board Of Regents Of The University Of Texas	Thymosin alpha 1
US4116951A (en) *	1977-04-22	1978-09-26	Hoffmann-La Roche Inc.	[Asn2 ]-thymosin α1 and analogs thereof
US4148786A (en) *	1978-06-26	1979-04-10	American Home Products Corporation	Analgesic polypeptide
DE2919592A1 (de) *	1979-05-15	1981-01-15	Max Planck Gesellschaft	Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
IT1238231B (it) *	1989-12-18	1993-07-12	Consiglio Nazionale Ricerche	Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori
FR2793684B1 (fr) *	1999-05-17	2001-08-10	Ethypharm Lab Prod Ethiques	Utilisation de microspheres biodegradables liberant un agent anticancereux pour le traitement du glioblastome, procede de preparation de ces microspheres et suspension les contenant
US6462017B1 (en) *	2000-05-01	2002-10-08	Sciclone Pharmaceuticals, Inc.	Method of reducing side effects of chemotherapy in cancer patients

2002
- 2002-10-12 UA UA20040705523A patent/UA77999C2/uk unknown
- 2002-12-10 NZ NZ533942A patent/NZ533942A/en unknown
- 2002-12-10 MX MXPA04005585A patent/MXPA04005585A/es active IP Right Grant
- 2002-12-10 DE DE60218896T patent/DE60218896T2/de not_active Expired - Lifetime
- 2002-12-10 KR KR1020107002516A patent/KR20100029844A/ko not_active Ceased
- 2002-12-10 WO PCT/US2002/039329 patent/WO2003049697A2/en not_active Ceased
- 2002-12-10 AU AU2002357115A patent/AU2002357115B2/en not_active Ceased
- 2002-12-10 US US10/498,050 patent/US20060166870A1/en not_active Abandoned
- 2002-12-10 IL IL16243402A patent/IL162434A0/xx unknown
- 2002-12-10 ES ES02804755T patent/ES2283653T3/es not_active Expired - Lifetime
- 2002-12-10 BR BR0214848-0A patent/BR0214848A/pt not_active IP Right Cessation
- 2002-12-10 PT PT02804755T patent/PT1461063E/pt unknown
- 2002-12-10 CN CNA028270819A patent/CN1615147A/zh active Pending
- 2002-12-10 AT AT02804755T patent/ATE356628T1/de active
- 2002-12-10 EA EA200400755A patent/EA005822B1/ru not_active IP Right Cessation
- 2002-12-10 EP EP02804755A patent/EP1461063B1/en not_active Expired - Lifetime
- 2002-12-10 JP JP2003550748A patent/JP2005516910A/ja active Pending
- 2002-12-10 DK DK02804755T patent/DK1461063T3/da active
- 2002-12-10 SI SI200230509T patent/SI1461063T1/sl unknown
- 2002-12-10 KR KR10-2004-7008939A patent/KR20040091611A/ko not_active Ceased
- 2002-12-10 PL PL02370829A patent/PL370829A1/pl not_active Application Discontinuation
- 2002-12-10 CA CA002469595A patent/CA2469595A1/en not_active Abandoned
2004
- 2004-07-08 NO NO20042927A patent/NO20042927L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
SI1461063T1 (sl)	2007-08-31
NO20042927L (no)	2004-09-09
IL162434A0 (en)	2005-11-20
CA2469595A1 (en)	2003-06-19
KR20040091611A (ko)	2004-10-28
EA005822B1 (ru)	2005-06-30
PT1461063E (pt)	2007-06-18
WO2003049697A2 (en)	2003-06-19
NZ533942A (en)	2007-01-26
ATE356628T1 (de)	2007-04-15
EP1461063A4 (en)	2005-08-31
KR20100029844A (ko)	2010-03-17
US20060166870A1 (en)	2006-07-27
DK1461063T3 (da)	2007-05-21
AU2002357115B2 (en)	2007-12-13
EA200400755A1 (ru)	2004-12-30
EP1461063B1 (en)	2007-03-14
AU2002357115A1 (en)	2003-06-23
WO2003049697A3 (en)	2004-01-15
DE60218896T2 (de)	2007-09-20
JP2005516910A (ja)	2005-06-09
BR0214848A (pt)	2004-11-09
CN1615147A (zh)	2005-05-11
ES2283653T3 (es)	2007-11-01
DE60218896D1 (de)	2007-04-26
UA77999C2 (en)	2007-02-15
MXPA04005585A (es)	2005-03-23
EP1461063A2 (en)	2004-09-29

Legal Events

Date	Code	Title	Description
2010-04-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
MY135766A (en)	2008-06-30	Quinolinones and naphthyridinones for treating inflammatory diseases
DE60112974D1 (en)	2005-09-29	Carbolinderivate
CY1107531T1 (el)	2013-03-13	Χρηση αναστολεων πρωτεασομης για την αγωγη των διαταραχων ξηρου οφθαλμου
ECSP024382A (es)	2003-02-06	Inhibidores de proteasa de serina
DE60216233D1 (en)	2007-01-04	Carbolinderivate
ATE433963T1 (de)	2009-07-15	Fab-i inhibitoren
DE60105418D1 (de)	2004-10-14	Serinprotease-inhibitoren
GB0011358D0 (en)	2000-06-28	Novel use
EP1089745A4 (en)	2002-03-20	OREGANO FOR TREATING INTERNAL PARASITES AND PROTOZOES
UY27203A1 (es)	2002-10-31	Bencimidazoles útiles en el tratamiento de la disfunción sexual
BR0210101A (pt)	2004-06-08	Combinações antineoplásticas
FI20000635A0 (fi)	2000-03-17	COMT-inhibiittoreiden käyttö analgeettina
MXPA02012470A (es)	2004-01-26	Inhibidores de fosfodiesterasa especificos para gmp ciclico.
BR0012675A (pt)	2002-04-09	Uso de inibidores de il-18
DE60127131D1 (de)	2007-04-19	Tricyclische imidazopyridine
IL162434A0 (en)	2005-11-20	Treatment of glioblastoma with thymosin-alpha 1
SE0302361D0 (sv)	2003-09-03	Inhibering av upptagning av monoamin
TR200302134T4 (tr)	2004-01-21	2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
IL139144A0 (en)	2001-11-25	Mycobacterial inhibitors
MXPA02012209A (es)	2003-06-04	Terapia combinada contra tumores que comprende derivados de bistamicina acriloilo substituida y agentes de alquilacion.
PT1042288E (pt)	2008-03-11	Inibidores de tripeptidil peptidase
PT1294395E (pt)	2006-08-31	Produto de combinacao compreendendo melagatrano e um inibidor do factor viia
ZA200209835B (en)	2003-12-04	Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or anti-metabolites.
TR200003084T2 (tr)	2001-02-21	Paroxetine askorbat
ECSP034752A (es)	2004-04-28	Benzimidazoles utiles en el tratamiento de la dinfuncion sexual